Not yet a member?Join now!|Lost password
Bioanalytical Systems Inc.
Bioanalytical Systems Inc.
02/07/2012 | Press release
Bioanalytical Systems to Release First Quarter Results Friday, February 10, 2011; Conference Call & Webcast Set For 11:00 a.m. EST
distributed by noodls on 02/07/2012 10:12
FOR MORE INFORMATION : Company Contact
Michael R. Cox
Chief Financial Officer
765.497.5829 mcox@BASInc.com
Agency Contact Neil Berkman Berkman Associates
310.477.3118 info@berkmanassociates.com
Bioanalytical Systems to Release First Quarter
Results Friday, February 10, 2011; Conference Call & Webcast Set For 11:00 a.m. EST
WEST LAFAYETTE, IN. -- February 7, 2012 -- Bioanalytical Systems, Inc. (NASDAQ:BASI) will release financial results for the fiscal 2012 first quarter ended December
31, 2011 at approximately 7:30 a.m. EST on Friday, February
10, 2011. BASi has scheduled a conference call at 11:00 a.m.
EST that morning to discuss its results for the quarter. To
participate in the call, dial 866.383.8009, passcode
#52616162.
A simultaneous webcast of the conference call may be accessed
online from the Investorstab at www.BASInc.com. The webcast will
be available for replay after 2:00 p.m. EST at this same
Internet address. For a telephone replay, dial 888.286.8010,
passcode #91679385 after
2:00 p.m. EST.
About Bioanalytical Systems, Inc.
BASi is a pharmaceutical development company providing contract research services and monitoring instruments to the world's leading drug development companies and medical research organizations. The company focuses on developing innovative services and products that increase efficiency and reduce the cost of taking a new drug to market. Visit www.BASInc.com for more about BASi.
This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to changes in the market and demand for our products and services, the development, marketing and sales of products and services, changes in technology, industry standards and regulatory standards, and various market and operating risks detailed in the company's filings with the Securities and Exchange Commission.
* * * * *
#4824